Skip to main content

tPA (Alteplase) Dosing for STEMI, Pulmonary Embolism & Stuck Prosthetic Valve



tPA (Alteplase) Dosing for STEMI, Pulmonary Embolism & Stuck Prosthetic Valve


tPA (alteplase) is a fibrin-specific thrombolytic used globally for rapid reperfusion in acute ischemic events. Unlike streptokinase, tPA has no antigenicity, works faster, and produces more targeted clot dissolution.


Below are the standard accepted alteplase regimens for:


STEMI


Acute Pulmonary Embolism


Prosthetic Valve Thrombosis (PVT / stuck valve)




---


1. Alteplase Dose for STEMI


Two main regimens are used: the accelerated 90-minute regimen (most common) and the 3-hour regimen.



---


A) Accelerated 90-Minute Regimen (Preferred)


Total dose: 100 mg


If weight ≥ 67 kg:


15 mg IV bolus


50 mg over 30 minutes


35 mg over the next 60 minutes



If weight < 67 kg:


15 mg IV bolus


Then 0.75 mg/kg over 30 minutes (max 50 mg)


Then 0.5 mg/kg over 60 minutes (max 35 mg)




---


B) 3-Hour Regimen (Alternative)


Total dose: 100 mg over 3 hours


1 mg/kg over 60 minutes


Then 1 mg/kg over the next 2 hours

(Max total 100 mg)



Used when accelerated protocol is not feasible.



---


2. Alteplase Dose for Acute Pulmonary Embolism


For massive PE (with hypotension, shock), tPA improves survival by rapidly reducing pulmonary pressures.


Standard PE Regimen


100 mg IV over 2 hours



(Heparin is held during infusion and restarted afterwards when aPTT < 2× normal.)



---


Alternative Low-Dose / Weight-Based Regimens


Used selectively in high-bleeding-risk patients:


50 mg over 2 hours


OR 0.6 mg/kg over 15 minutes (max 50 mg)



These are institution-dependent.



---


3. Alteplase for Stuck Prosthetic Valve (Prosthetic Valve Thrombosis)


tPA is often preferred over streptokinase because it is fibrin-specific, faster, and sometimes safer in controlled low-dose infusions.


There are three accepted clinical strategies:



---


A) “Ultraslow” Low-Dose Infusion (most endorsed today)


1 mg/hour for 25 hours (total 25 mg)

Followed by repeat cycles depending on response.



This approach (e.g., TROIA and PROMETEE protocols) reduces:


Major bleeding


Embolization


Need for surgery




---


B) Slow Infusion, Low Dose


25 mg alteplase infused over 6 hours


Repeat cycle up to 2–3 times if needed


No bolus



Used for left-sided valves, especially mitral.



---


C) Accelerated Regimen


Used in right-sided valves or when rapid thrombolysis is necessary.


10 mg bolus, then


90 mg infusion over 2 hours

(Max total 100 mg)



Higher embolization risk → used only in selected cases.



---


Summary Table


Condition Standard tPA Dose Alternative Dose


STEMI 100 mg (15 mg bolus → 50 mg/30 min → 35 mg/60 min) 100 mg over 3 hours

PE 100 mg over 2 hours 50 mg over 2 hr OR 0.6 mg/kg over 15 min

Stuck Valve 1 mg/hr × 25 hr (ultraslow) 25 mg/6 hr OR 100 mg over 2 hr



Comments

Popular posts from this blog

π˜Όπ™£π™©π™žπ™˜π™€π™–π™œπ™ͺπ™‘π™–π™©π™žπ™€π™£ π˜Όπ™›π™©π™šπ™§ π™Žπ™©π™§π™€π™ π™š

 π˜Όπ™£π™©π™žπ™˜π™€π™–π™œπ™ͺπ™‘π™–π™©π™žπ™€π™£ π˜Όπ™›π™©π™šπ™§ π™Žπ™©π™§π™€π™ π™š in  Patient with AF and acute IS/TIA European Heart Association Guideline recommends: • 1 days after TIA • 3 days after mild stroke • 6 days after moderate stroke • 12 days after severe stroke Early anticoagulation can decrease a risk of recurrent stroke and embolic events but may increase a risk of secondary hemorrhagic transformation of brain infarcts.  The 1-3-6-12-day rule is a known consensus with graded increase in delay of anticoagulation between 1 and 12 days after onset of ischemic stroke or transient ischemic attack(TIA), according to neurological severity based on European expert opinions. However, this rule might be somewhat later than currently used in a real-world practical setting.

Learn Echocardiography | Standard Protocol for Performing Comprehensive Echocardiogram | Explained with Images and Videos

  If you are just starting to learn echocardiography, you will find that learning the full echo examination protocol will be immensely useful. The full protocol will provide a solid foundation for your career in echo. I personally found that once I could execute the standard protocol flawlessly, I was able to add and refine additional echo scanning skills while deepening my understanding of the purpose of each echo image. The echo protocol illustrated in this article is the same one we currently use for all our patients in the hospital and meets or exceeds the standards of American Society of Echocardiography (ASE) for an adult echocardiography examination. The protocol presented here is meant as a guideline and does not cover every aspect (such as off axis views) of an echo examination. Also other hospitals will probably have slight variations of this protocol depending on the lab's needs, which is normal. This article's main purpose is to provide a solid foundation for ...

Brugada ECG vs Incomplete Right Bundle Branch Block (iRBBB)

Brugada ECG vs Incomplete Right Bundle Branch Block (iRBBB) Why this differentiation matters Brugada pattern is a malignant channelopathy associated with sudden cardiac death, while incomplete RBBB is usually a benign conduction variant. Mislabeling Brugada as iRBBB can be fatal; overcalling iRBBB as Brugada can lead to unnecessary anxiety and ICD implantation. --- 1. Basic Definitions Brugada ECG Pattern Primary repolarization abnormality Genetic sodium-channel disorder Characteristic ST-segment elevation in V1–V3 Risk of ventricular fibrillation and sudden death Incomplete RBBB (iRBBB) Depolarization abnormality Delay in right ventricular conduction Common in healthy individuals Usually asymptomatic and benign --- 2. ECG Morphology: Side-by-Side Comparison QRS Duration Brugada: QRS usually <120 ms iRBBB: QRS <120 ms, but with RBBB morphology --- V1–V2 Pattern (Key Differentiator) Brugada Pseudo-RBBB appearance ST elevation ≥2 mm ST segment is coved or saddleback Terminal QRS bl...